Phase 1b/2a, Open-label Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC

Clinical trial NCT03732274 · COMPLETED

Trial details

NCT number: NCT03732274
Sponsor: MedPacto, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Metastatic

Start date: 2019-02-11
Primary completion: 2024-05-17
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.